About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pick Up Service

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

46.48 -0.27 (-0.59%)

Streaming Delayed Price Updated: 10:04 AM EDT, Jun 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

29 30 Next >

Boston Scientific Corporation Should Continue Uptrend & Remain Supported ↗

January 30, 2024

Boston Scientific Corporation develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments.

Via Talk Markets

Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗

January 29, 2024

An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.

Via Benzinga

Topics Artificial Intelligence

Looking Into Boston Scientific's Recent Short Interest ↗

January 23, 2024

Via Benzinga

Demystifying Boston Scientific: Insights From 10 Analyst Reviews ↗

January 16, 2024

Via Benzinga

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst ↗

January 23, 2024

Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.

Via Benzinga

Chart Of The Day: Boston Scientific - Revenue Growth Potential ↗

January 18, 2024

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

Via Talk Markets

Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling ↗

January 17, 2024

The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

January 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Why Axonics Stock Soared Today ↗

January 08, 2024

The medical device maker agreed to be acquired by Boston Scientific.

Via The Motley Fool

Health Care Company Boston Scientific Announces Acquisition of Axonics ↗

January 08, 2024

Via Benzinga

7 Healthcare Stocks Taking Medicine to the Next Level ↗

January 14, 2024

With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.

Via InvestorPlace

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗

January 12, 2024

The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.

Via Investor's Business Daily

Topics ETFs

5 A-Rated Stocks to Buy ASAP in 2024 ↗

January 10, 2024

2024 is ushering in a new era for investors, and these top-notch, A-rated stocks to buy are likely to be market winners. Here's why.

Via InvestorPlace

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years ↗

January 03, 2024

Via Benzinga

Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) ↗

December 29, 2023

Via Benzinga

NYSE:BSX may be ready to breakout. ↗

December 28, 2023

BOSTON SCIENTIFIC CORP (NYSE:BSX) Reveals Intriguing Technical Aspects. Here's What You Need to Know.

Via Chartmill

10 Top Stocks With a Strong Buy Rating Right Now ↗

January 09, 2024

Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch.

Via InvestorPlace

January 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 08, 2024

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today ↗

December 21, 2023

Via Benzinga

(BSX) - Analyzing Boston Scientific's Short Interest ↗

December 19, 2023

Via Benzinga

Why Is Axonics (AXNX) Stock Up 20% Today? ↗

January 08, 2024

Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific.

Via InvestorPlace

Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today? ↗

January 08, 2024

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7

Via Benzinga

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value ↗

January 08, 2024

The year's biggest medical conference kicked off with a melee of buyout news.

Via Investor's Business Daily

Axonics Announces Definitive Agreement to be Acquired by Boston Scientific

January 08, 2024

From Axonics, Inc.

Via Business Wire

Stock Picks 2024: 7 Trailblazers Using AI to Revolutionize Their Industries ↗

January 03, 2024

Via InvestorPlace

Topics Artificial Intelligence

Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday ↗

December 29, 2023

Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get

Via Benzinga

Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return ↗

December 22, 2023

Via Benzinga

This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch ↗

December 15, 2023

Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising

Via Benzinga

Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest Holdings ↗

December 14, 2023

These two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023.

Via The Motley Fool

Topics ETFs

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Boston Scientific (NY:BSX)

All News about Boston Scientific

Sections

Services

Contact Information

Follow Us